Abbott Labs to buy Solvay for $6.6 billion, gain spot in vaccines market
Posted: September 29, 2009 at 5:41 a.m.
Abbott Laboratories on Monday said it would pay $6.6 billion for the pharmaceutical business of Belgian chemicals maker Solvay in a move to further expand internationally and add to its product portfolio.
This story is only available from the archives. Click here to contact the online desk.
Business, Pages 19, 24 on 09/29/2009
(Advertisement)
« Previous Story
Property given to lender to end suit
Metropolitan National Bank and representatives of the Bob L. Gaddy Trust agreed to a consent judgment in a $27 million lawsuit filed by the bank on Sept. 22, leaving the le... Read »
Next Story »
Xerox to buy Affiliated Computer
Xerox Corp. agreed to buy Affiliated Computer Services Inc. for $6.4 billion in its biggest purchase, shifting to technology services as sales of its printing equipment dro... Read »
Comments
To report abuse or misuse of this area please hit the "Suggest Removal" link in the comment to alert our online managers. Please read our comment policy.
Use the comment form below to begin a discussion about this content.
Registration is required to make comments. Click here to LOGIN.
You can register for FREE to post comments and receive alerts.